×

Perjeta trial a setback for Roche, not a disaster: Novasecta managing partner

4:03 AM ET Tue, 6 June 2017

John Rountree, managing partner at Novasecta, discusses the fallout of a disappointing breast cancer drug trial for pharmaceutical firm Roche.